- Home
- GP vs ACXP Comparison
GP vs ACXP Comparison
Compare GP & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GP
- ACXP
- Stock Information
- Founded
- GP 2010
- ACXP 2017
- Country
- GP Canada
- ACXP United States
- Employees
- GP N/A
- ACXP N/A
- Industry
- GP Construction/Ag Equipment/Trucks
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- GP Consumer Discretionary
- ACXP Health Care
- Exchange
- GP Nasdaq
- ACXP Nasdaq
- Market Cap
- GP 12.7M
- ACXP 8.4M
- IPO Year
- GP 2020
- ACXP 2021
- Fundamental
- Price
- GP $0.43
- ACXP $0.47
- Analyst Decision
- GP Strong Buy
- ACXP Strong Buy
- Analyst Count
- GP 2
- ACXP 2
- Target Price
- GP $2.33
- ACXP $10.00
- AVG Volume (30 Days)
- GP 84.8K
- ACXP 18.7M
- Earning Date
- GP 08-13-2025
- ACXP 08-08-2025
- Dividend Yield
- GP N/A
- ACXP N/A
- EPS Growth
- GP N/A
- ACXP N/A
- EPS
- GP N/A
- ACXP N/A
- Revenue
- GP $20,656,035.00
- ACXP N/A
- Revenue This Year
- GP N/A
- ACXP N/A
- Revenue Next Year
- GP $94.25
- ACXP N/A
- P/E Ratio
- GP N/A
- ACXP N/A
- Revenue Growth
- GP N/A
- ACXP N/A
- 52 Week Low
- GP $0.36
- ACXP $0.30
- 52 Week High
- GP $1.90
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- GP 55.17
- ACXP 52.38
- Support Level
- GP $0.38
- ACXP $0.45
- Resistance Level
- GP $0.43
- ACXP $0.59
- Average True Range (ATR)
- GP 0.03
- ACXP 0.08
- MACD
- GP 0.01
- ACXP -0.01
- Stochastic Oscillator
- GP 79.08
- ACXP 27.06
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.